Direkt zum Inhalt
Merck
Alle Fotos(1)

Key Documents

View All Documentation

B1385

Supelco

Butoxamin -hydrochlorid

analytical standard, for drug analysis, mixture of diastereomers

Synonym(e):

α-[1-(tert.-Butylamino)-ethyl]-2,5-dimethoxy-benzylalkohol

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C15H25NO3 · HCl
CAS-Nummer:
5696-15-1
Molekulargewicht:
303.82
EG-Nummer:
227-169-5
MDL-Nummer:
MFCD00135781
UNSPSC-Code:
41116107
PubChem Substanz-ID:
329773182
NACRES:
NA.24

Qualität

analytical standard, for drug analysis

Qualitätsniveau

200

Methode(n)

HPLC: suitable
gas chromatography (GC): suitable

Anwendung(en)

forensics and toxicology
pharmaceutical (small molecule)
veterinary

Format

neat

SMILES String

Cl.COc1ccc(OC)c(c1)C(O)C(C)NC(C)(C)C

InChI

1S/C15H25NO3.ClH/c1-10(16-15(2,3)4)14(17)12-9-11(18-5)7-8-13(12)19-6;/h7-10,14,16-17H,1-6H3;1H

InChIKey

URPAECSKKQLCII-UHFFFAOYSA-N

Allgemeine Beschreibung

Butoxamine hydrochloride is a β-andrenoceptor antagonist, which shows β2-selectivity.

Anwendung

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Piktogramme

Exclamation mark
GHS07

Signalwort

Warning

H-Sätze

H302,H319

Gefahreneinstufungen

Acute Tox. 4 Oral - Eye Irrit. 2

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Persönliche Schutzausrüstung

dust mask type N95 (US), Eyeshields, Gloves

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number
0000381174
0000381174
0000309977
0000267702
SLCQ3339

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Suche nach COA

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Claudio Molinari et al.
Endocrinology, 148(8), 4080-4090 (2007-04-28)
Prolactin has been associated with many effects and has been implicated in the pathogenesis of pregnancy-related hypertensive disorders, although little is known about its vascular effects. The present study was designed to determine the primary effect of prolactin on regional
Nozomu Abe et al.
BioMed research international, 2020, 3214186-3214186 (2020-05-29)
Adrenaline quickly inhibits the release of histamine from mast cells. Besides β2-adrenergic receptors, several in vitro studies also indicate the involvement of α-adrenergic receptors in the process of exocytosis. Since exocytosis in mast cells can be detected electrophysiologically by the
Elena Grossini et al.
Endocrinology, 148(2), 806-812 (2006-11-18)
The peptide ghrelin has been linked to the atherosclerotic process and coronary artery disease. We planned to study, for the first time, the primary effects of ghrelin on the intact coronary circulation and determine the mechanisms involved. In 24 sodium
Jiayin Lu et al.
International journal of molecular sciences, 22(3) (2021-02-06)
Restraint stress causes various maternal diseases during pregnancy. β2-Adrenergic receptor (β2-AR) and Forkhead transcription factor class O 1 (FOXO1) are critical factors not only in stress, but also in reproduction. However, the role of FOXO1 in restraint stress, causing changes
Nan Yang et al.
Respiratory research, 22(1), 65-65 (2021-02-25)
Airway inflammation is a key feature of chronic obstructive pulmonary disease (COPD) and inhaled corticosteroids (ICS) remain the main treatment for airway inflammation. Studies have noted the increased efficacy of ICS and long-acting beta 2 agonist (LABA) combination therapy in
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.